{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T18:30:32Z","timestamp":1720636232857},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.hrthm.2006.12.001","type":"journal-article","created":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T18:08:21Z","timestamp":1165514901000},"page":"S34-S39","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S","title":["Anticoagulation in atrial fibrillation: A contemporary viewpoint"],"prefix":"10.1016","volume":"4","author":[{"given":"D. George","family":"Wyse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2006.12.001_bib1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.154.13.1449","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2006.12.001_bib2","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.12.001_bib3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib4","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC Member Countries: The Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2006.12.001_bib5","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2006.12.001_bib6","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.12.001_bib7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): a randomized controlled trial","volume":"362","author":"Olson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2006.12.001_bib8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.293.6.690","article-title":"Ximelagatran vs. warfarin in patients with nonvalvular atrial fibrillation: a randomized trial","volume":"293","author":"Albers","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2006.12.001_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2006.12.001_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) Study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib12","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-006-7622-y","article-title":"Rational and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: TRENDS","volume":"15","author":"Glotzer","year":"2006","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2006.02.016","article-title":"ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT)","volume":"152","author":"Hohnloser","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2006.12.001_bib15","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2006.12.001_bib16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ahj.2004.11.015","article-title":"Factors affecting bleeding risk during anticoagulation therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study","volume":"149","author":"Di Marco","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2006.12.001_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.amjcard.2004.06.038","article-title":"Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study)","volume":"94","author":"Sam","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-138-10-200305200-00011","article-title":"Lessons from the Stroke Prevention in Atrial Fibrillation trials","volume":"138","author":"Hart","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2006.12.001_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.amjcard.2004.06.023","article-title":"Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study)","volume":"94","author":"Friberg","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation","volume":"141","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2006.12.001_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2006.12.001_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin or both after myocardial infarction","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2006.12.001_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2004.05.084","article-title":"Comparative effects of antiplatelet, anticoagulant or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study","volume":"44","author":"Perez-Gomez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib24","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.jacc.2005.07.062","article-title":"Trials and tribulations of non-inferiority: the ximelagatran experience","volume":"46","author":"Kaul","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ahj.2005.06.026","article-title":"Rational and design of ACTIVE: the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events","volume":"151","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2006.12.001_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0735-1097(96)00427-5","article-title":"Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation","volume":"29","author":"Sohara","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib27","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2006.12.001_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0735-1097(02)02052-1","article-title":"Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion","volume":"40","author":"Gallagher","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.12.001_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/01.CIR.0000120509.64740.DC","volume":"109","author":"Stellbrink","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.12.001_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.hrthm.2006.03.003","article-title":"How to perform encircling ablation of the left atrium","volume":"3","author":"Pappone","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2006.12.001_bib31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.106.641225","article-title":"Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation for atrial fibrillation","volume":"114","author":"Oral","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.12.001_bib32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2006.12.001_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106022314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106022314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:59:37Z","timestamp":1547168377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527106022314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1547527106022314"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2006.12.001","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}